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Coagulase-negative staphylococci (CoNS) are a group of bacteria that 
inhabit healthy human skin and mucosae, and hence, have long been 
considered non-pathogenic. However CoNS are currently recognized as 
important etiological agents of healthcare-associated infections, being 
particularly associated with patients with indwelling medical devices, due 
to their ability to form biofilms on the surface of such devices. Along with 
the overuse of antibiotics that resulted in a dramatic increase in resistant 
bacteria, CoNS bacteria within biofilms are intrinsically more tolerant to 
antimicrobial agents than their planktonic counterparts. As a 
consequence, biofilms are frequently associated with the development of 
persistent infections. Hence, the search for new prophylactic and 
therapeutic strategies for the management of CoNS biofilm-associated 
infections is essential. Herein, we studied the susceptibility of CoNS 
planktonic and biofilms cells to carvacrol, one of the most common 
components of essential oils found in aromatic plants. Carvacrol showed 
a significant effect on the viability of both planktonic and biofilm cells even 
after a short period of interaction. Low concentrations of carvacrol, such 
as 2 µM, were sufficient to reduce up to 3 Log10 of the initial challenge. 
Importantly, the antimicrobial effect of carvacrol on CoNS planktonic cells 
was greater than the one observed with vancomycin, one of the most 
frequently used antibiotics to treat staphylococcal infections. Overall, 
these results showed that carvacrol is a potential antimicrobial agent, 
which may be used in the future for the prevention and/or treatment of 
CoNS-associated infections. 
 
 
 
 
